Corrective Assignment to Correct the Name of the Assignee from Beijjng Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd to Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd Previously Recorded on Reel 70075 Frame 544. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2025-02-10 Pages: 8

Assignor

Executed: 2025-01-23

Assignee

ROOM 332, 3RD FLOOR, BUILDING 3, TIANDI LINFENG, NO. 1 YONGTAIZHUANG NORTH ROAD, HAIDIAN DISTRICT, BEIJING, 100192, CHINA

Covered Properties (2)

Microrna and Uses Thereof in Prevention and/or Treatment of Fibroplasia Medical Sign and/or Syndrome

Patent: 11,471,476 →

Application: 16/498,435 →

Publication: US 2021/0085706

Microrna and Uses Thereof in Prevention and/or Treatment of Fibroplasia Medical Sign and/or Syndrome

Patent: 12,427,164 →

Application: 17/936,820 →

Publication: US 2023/0293570

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.